awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26764899-6F981CFB-4712-4B63-882C-C2BD82519A07
Q26764899-6F981CFB-4712-4B63-882C-C2BD82519A07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764899-6F981CFB-4712-4B63-882C-C2BD82519A07
Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications
P2860
Q26764899-6F981CFB-4712-4B63-882C-C2BD82519A07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764899-6F981CFB-4712-4B63-882C-C2BD82519A07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adc9b8309e0d479b57345af5a4d2bd7d22e9819a
P2860
Phase II trial of sorafenib in advanced thyroid cancer.